Fernando Bril, MD

Mon., January 26, 2026, 1-2 pm Eastern

CME Credits: 1

Price: Free to Members

Primary care providers and obesity specialists play a critical role in the early identification of metabolic dysfunction–associated steatotic liver disease (MASLD) and liver fibrosis, including appropriate treatment and timely referral to hepatology when indicated. This presentation will review practical strategies for screening patients with overweight, obesity, or type 2 diabetes for liver disease and will discuss evidence-based management approaches for patients with significant liver disease.